Sunday, December 20, 2020

Glenmark Pharma gets tentative nod from USFDA for anticoagulant drug

Glenmark Pharma gets tentative nod from USFDA for anticoagulant drug The approved product is a generic version of Boehringer Ingelheim Pharmaceuticals’ Pradaxa capsules. Pradaxa is used to prevent blood clots from forming because of certain irregular heart rhythm.

from Moneycontrol Business News https://ift.tt/3mFRhBk
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Market moves driven more by psychology than fundamentals: Samir Arora

Indian stock markets are caught between global worries and strong domestic company profits. Foreign investor activity, oil price swings, and...